Financial Performance - For the three months ended September 30, 2024, the company reported a net income of 1,059,413,drivenbyinterestincomeof1,588,812 from investments held in the Trust Account[103]. - For the nine months ended September 30, 2024, the company achieved a net income of 3,218,561,withinterestincometotaling4,724,702[106]. - As of September 30, 2024, the company had investments in the Trust Account amounting to 123,794,068,including7,069,068 of interest income[112]. IPO and Related Costs - The company completed its IPO on June 16, 2023, raising gross proceeds of 115,000,000fromthesaleof11,500,000Unitsat10.00 per Unit[108]. - The company incurred 5,368,092inIPO−relatedcosts,whichincludedacashunderwritingdiscountof2,300,000[109]. Liquidity and Going Concern - As of September 30, 2024, the company had cash of 1,460,218availableforoperationalactivitiesandduediligenceonpotentialtargetbusinesses[114].−ThecompanyhasdeterminedthatiftheInitialBusinessCombinationdoesnotoccurbyDecember16,2024,itmayfacemandatoryliquidation,raisingsubstantialdoubtaboutitsabilitytocontinueasagoingconcern[117].−Thecompanyhasnolong−termdebtoroff−balancesheetarrangementsasofSeptember30,2024[118].UseofFunds−ThecompanyplanstousesubstantiallyallfundsintheTrustAccounttocompletetheInitialBusinessCombinationandforworkingcapitalofthetargetbusiness[113].AccountingandInternalControls−ThecompanyhasidentifiedacriticalaccountingestimaterelatedtoClassAcommonstocksubjecttopossibleredemption,amountingto122,820,627 as of September 30, 2024[125]. - Management believes that recently issued accounting standards will not materially affect the unaudited condensed financial statements[126]. - Disclosure controls and procedures were evaluated as effective at a reasonable assurance level as of September 30, 2024[127]. - No changes in internal control over financial reporting occurred during the fiscal quarter of 2024 that materially affected internal controls[128]. Legal and Risk Factors - There are no legal proceedings reported by the company[130]. - No material changes to risk factors have been disclosed since the Annual Report on Form 10-K[130].